-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on Haemonetics, Raises Price Target to $142

Benzinga·11/05/2026 17:34:06
Listen to the news
BTIG analyst Marie Thibault maintains Haemonetics (NYSE:HAE) with a Buy and raises the price target from $130 to $142.